Gummies Week · UP TO 75% OFF UP TO 75% OFF · Gummies Week Ends in This week only · 76 gummies picks marked down Shop the deals →
Go back
Refer for $20
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Study: ‘Little Evidence’ That Cannabis Harmfully Impacts Cognition in People with HIV

Cannabis is widely used to help mitigate the symptoms of a variety of conditions and diseases. Specifically, a number of state medical cannabis programs list HIV/AIDS as a qualifying condition, as cannabis can help to eliminate a variety of symptoms associated with HIV/AIDS treatment. Though, some clinicians have expressed concern how regular cannabis treatments in this regard may impact patient cognition.  Researchers affiliated with the University of California at San Diego sought to investigate the cognitive impacts of cannabis use in people with HIV through a newly published meta-analysis in the journal Current HIV/AIDS Reports.  Ultimately, they conclude that neither the use of whole-plant cannabis or cannabis-based medicines are associated with significant cognitive changes in those with HIV. In the study abstract, researchers note the potential benefits that cannabis use can offer patients with HIV while recognizing this population’s “high burden of persisting neurocognitive impairment” and physician concerns with adding cannabis into the mix, specifically its potential cognitive effects. Cannabis use among those with HIV is far from a new trend. The U.S. Food and Drug Administration first approved synthetic oral THC capsules (dronabinol) to treat HIV-induced cachexia, or loss of appetite, in 1985. Additionally, surveys have consistently affirmed that cannabis use is common among people with HIV, with one 2007 study predating the bulk of medical reform measures in the U.S. still finding that more than 60% of HIV/AIDS patients self-identified as medical cannabis users.  Another more recent 2022 study noted that 77% and 34% of people with HIV reported lifetime and past-year cannabis use, respectively. While some of these patients report recreational use as one reason, research over the years has found that cannabis is largely used among people with HIV to stimulate appetite, reduce pain, relax and ease anxiety and help with sleep. With plenty of existing data to pull from, researchers reviewed data from 34 clinical studies to determine the extent that cannabis impacts cognition among patients with HIV. The results, according to the study, revealed that there is “little evidence” to support that cannabis has a harmful impact on cognition among those with HIV. “Overall, the number of reported adverse effects were largely outnumbered by beneficial or null findings, providing insufficient support for the detrimental impact of CU [cannabis use] on cognition in PWH [people with HIV],” researchers reported, adding that the results suggest both cannabis and cannabis-based medications can be prescribed to people with HIV “while posing little threat to cognitive function.” The topic of cannabis use and cognition has seen a recent uptick in popularity, especially given recent conversations surrounding cannabis-induced psychosis (which has largely been linked to pre-existing conditions and vulnerabilities and is not a widespread issue among cannabis consumers, with some advocates arguing that the focus on this topic is a repackaged version of “Reefer Madness” propaganda from decades past). Of course, it’s important to look at the full picture and recognize how cannabis use and abuse may impact a variety of populations, and myriad studies attempt to look a bit more broadly at the topic. Recent research shows that cannabis users may actually have a lower chance of cognitive decline overall.  Previous studies have also noted links between heavy cannabis use and cognitive performance, though researchers noted that particular products used, methods of consumption and the reasons for use can also impact cognitive effects associated with cannabis use. Another recent study similarly found that adolescents who occasionally use cannabis do not see cognitive differences compared to those who abstain, once again highlighting a distinction surrounding frequency of use among other variables.

https://hightimes.com/

Intentional Medicine

Entering the gardens of Sun Roots Farm in Covelo in Mendocino County is like entering a botanical fever dream. Giant purple cannabis plants rule instead of humans, and weed flowers the size of buildings sway under the weight of their own colas. Below their sticky canopy, medicinal and edible companion plants twist, bloom, and communicate in soil alive with insects and mycelium. This sungrown Eden is a place where cannabis is encouraged to express her wildest potential. According to Forrest Gauder and Patricia Vargas, the husband-and-wife team of regenerative farmers who founded Sun Roots in 2015, the less human intervention on this potential, the better. “The plant has its own potential that is not influenced by humans,” Vargas said. “When it’s exposed to a multitude of beneficial components, such as high-quality soil, the energy of the sun and the moon, clean water, clean air, and the intention we put into caring for it, everything works in synchronicity.” Sun Roots is a regenerative farm, meaning its practices are centered around healing and regenerating life on earth by improving soil health, bolstering native biodiversity, carbon sequestration (capturing and storing carbon dioxide to reduce the amount of carbon dioxide in the atmosphere), water conservation, and enriching the health of the overall Covelo community.  As opposed to the extractive farming practices often employed by cannabis farms, in which pesticides kill everything in proximity to the plants, poisoning the environment and sometimes even the consumer, regenerative agriculture uses a closed-loop system of cultivation that produces no waste and nurtures the environment while doing so. While Vargas grew up in urban Connecticut and Gauder in the hills above Covelo, California a shared belief in the power of plants ultimately led them to one another.  Vargas’s ancestors were tobacco farmers from Puerto Rico, with her mother often in the garden as she was growing up. She attended Keene State College in New Hampshire, which she describes as “super hippy dippy.” After 10 years of working on farms in the area, she traveled to California through WWOOF (Worldwide Opportunities on Organic Farms) to grow vegetables year-round. Gauder is a second-generation cannabis farmer who grew up in the self-reliant culture of the traditional market. “We were taught by my father to grow our own food on an off-grid apple orchard, homestead-style,” he said. “I’ve always been drawn to the cannabis plant. I love learning from the plant and building the wisdom I gain from it every year. In the same way that it grows, I grow too.” Shortly after Vargas moved to Covelo to work on a mutual friend’s weed farm, she and Gauder found each other one summer night on a full rose moon. “I decided to go to a drum circle, and Forrest ended up being there,” she said. “We immediately walked up to each other like magnets. We just knew.” At that time, Covelo was a different place. Like all corners of the Emerald Triangle, the endless pitfalls of legalization drastically altered the existence of cannabis farmers. “When I came here, there were so many people from all over the world,” said Vargas. “There was such a robust culture and an energy of excitedness and abundance. The wildlife was so healthy, and the landscape was so beautiful.” When state voters approved a legal adult-use cannabis marketplace in 2016, things began to change. “Prices just started dropping,” Vargas said. “Now your profit wasn’t as high because you’re giving all your money to compliance people or taxes. Everybody’s getting a cut. Things went from being amazing, feeling like we were on top of the world, to feeling like we had a ball and chain attached to us.” The “green rush” and its subsequent fall negatively impacted the environment of Covelo, as well. Due to its rural, secluded location, people began implementing extremely destructive farming tactics to turn a profit as fast and as recklessly as possible. They burned through the valley, leveling huge swaths of forest for makeshift mega-grows, siphoning water from the river, covering mountaintops with plastic tarps, and leaving the trash when they were done. “We were all like, ‘This is the dark side of this whole culture,’” Vargas said. “That’s why a lot of us going legal were pushing for environmental rights because we saw it happening in our own community.” The reason Covelo is such a hotbed of cannabis activity is because of its ideal soil. Covelo is located in Round Valley, which is exactly what it sounds like: a big round valley with a flat bottom and hills extending up from its perimeter. It used to be a swampy floodplain for Round Valley Creek that ran through it until colonizers built an outlet that drained the valley in the 1920s. “The mountains drained into the valley, creating these deposited silt beds that are particularly rich in the area beneath our farm,” Gauder said. “There are three to four feet of chocolate-colored soil. It’s really beautiful, full of worms and bugs and life and nutrients. Just think of all the stuff that’s been deposited there throughout the years. “Our farm is one of the best spots in the valley. Some parts are too rocky or sandy or dense with clay. But where we are, it’s a perfect top layer of dirt for growing weed and food, then under that, it turns to rocks and sand, so it drains really well.” Sun Roots Farm is the definition of true “living soil,” a hallmark of regenerative agriculture, which has become a buzzy marketing term for greenwashing brands in the industry. While we often see the term applied to indoor grows who put a couple of earthworms in their pots and then dump the soil after harvest, true living soil is cared for and nurtured like a living organism. “Anyone who’s dumping every year, that’s not living soil,” said Vargas. “Living soil is living. You continue to work with it. You don’t just throw it away. You feed it through compost and biomass and mulching, and the plants that you create. If you dump it, how are you honoring the life of your soil?” “Because you’re adding more decomposing matter every year, you build it with the aim of disturbing the soil as little as possible,” added Gauder. “The less you disturb it, the more mycelial networks that are going to be present, the richer your soil, and the greater the ecosystem.” This idea that the plants, the soil, and the ecosystem they create thrive in the absence of human intervention is integral to the Sun Roots Farm philosophy. Their hands-off approach to cultivation is born from a deep trust in nature and her ability to do what she does better than we can. The thing about plants is that without them, we die. But without humans, plants thrive. Humans often interpret cultivation as manipulating the plant to make it do what we want. Sun Roots does the opposite. “It’s about allowing things to be their most natural and not interfering too much,” said Vargas. “I think with cannabis, a lot of us think—or the habit has been—to go out and buy soil or buy these products for this, to manage this, and control that. What we’ve learned in our practices is that nature is the ultimate teacher. Nature knows what she’s doing. Leave her alone, and let her do her thing.” One of the most beneficial components of Sun Roots’s regenerative, closed-loop system is their herd of alpacas. Not only do they help control various plant populations on the property, assisting with fire suppression, but their manure is an incredible fertilizer for the cannabis. “Part of regenerative agriculture is stacking functions, so when we invest in something, we need to make sure it has many uses,” said Gauder. “We’re using their manure as our main fertilizer for all of the crops. They have super hygienic dung piles, so it’s easy to collect, which means that we don’t have to run tractors or burn fossil fuels. They also slim down the brush to a certain height, creating a perfect distance for fire suppression.” Instead of ripping out plants by their root systems like many other livestock, alpacas maintain the seed cycles of native plants on the farm through rotational grazing, composting them in their stomachs, and redistributing the seeds back into the earth through their manure. “We also use their shearings as mulch on the earth, which creates a nice layer of fiber and moisture barrier for decomposing nutrients,” said Vargas. “The mycelium love it. Then we’re able to draw in species like edible mushrooms that feed us and the bees and can also be put into fertilizer teas. The cycle continues in a circular motion where everything is in constant use, and nothing is ever wasted.” Sun Roots flower is a culmination of intention, high-vibe growing practices, and, of course, a little magic. Famous for their sparkly, dark purple nugs and fruity, complex terpene profiles, their flower has an energetically dense high that transcends just getting stoned. They specialize in a Velvet lineage, which started as the sister plants (or different phenotypes) of Jah Goo, a cross of Purple Jasmine and Afghan Goo that is a uniquely acclimated cultivar made in Covelo. Two plants in particular stood out over the years, with which they have continued to create seeds. The first is the crystal-laden Velvet Purps, with its magenta trichomes, neon leaves, and a high that leaves you happy, buoyant, and at ease. The second is their Magu’s Fruit, a personal favorite of mine for her uplifting and effervescently creative energy, originally dubbed Silver Goo for the silver gown of buds that cascade down the giant plants. These varieties, as well as a number of crosses like Velvet La Flor, Magu’s Velvatron, and Velvet Citrine, are available through retail shops such as Redwood Roots and Solful.  “This is intentional medicine for spiritual health,” said Vargas. “It’s not just recreational. I’m here to get stoned, yes, but a lot of us are using this for our mental health. So we make sure that we’re putting positivity into this. We need more positivity in this world. We need more love in this world. For us, to be growing a plant that we get to share with the world is an honor. Our greatest hope is that people will feel the medicine behind it. That they will take that seed they’ve been given, and they go on and share it with others.” This article was originally published in the April 2024 issue of High Times Magazine.

https://hightimes.com/

The Gift of Flavor

Chef Maverick is as multi-talented as they come, and the titles of chef, caterer, product developer, Chopped 420 competitor, author, businessperson, brand designer, and more are all just a glimpse of explaining her skillset. From catering small- and large-scale dining events (both with cannabis-infused dishes and non-infused meals) to creating her line of infused sauces and snacks, she’s highly ambitious and strives to craft flavor-packed foods using only the best ingredients. Maverick is a Los Angeles native who discovered her passion for food at 5 years old and has spent her life cooking for her friends and family. Instead of pursuing a culinary education in college, she attended school in Georgia and Tennessee and earned her bachelor’s degree in computer science and software engineering. During her college education, she also worked at numerous restaurants, from Red Lobster to Applebee’s and IHOP, and would experiment with cooking and recreating menu items from those businesses at home. “I would go home and recreate certain things that I liked, that worked, or put my little twist on certain things is basically how I developed my culinary skill set,” Maverick explains. After graduation, she spent nearly five years as a corporate sales rep. Her culinary career took off in 2015 when she moved back to Los Angeles and began building her reputation as a private chef and caterer. Her introduction to cannabis came a few years later when she was diagnosed with Crohn’s disease and multiple sclerosis, in addition to learning that she was allergic to gluten and soy. Edibles helped her manage the symptoms of her conditions. Still, she found that the selection was limited—the cannabis industry was oversaturated with sweets, but somehow, none of them catered to her new dietary restrictions. “I realized at the time that edibles were very popular, but a majority of the edibles that were available were mostly gummies, cookies, brownies, you know, things like that,” Maverick says. “I also didn’t see any specific gluten-free, vegan, soy-free options. And because I found out I had allergies to gluten and soy, I couldn’t really eat any of the edibles that were available at the time.” This prompted her to develop a line of infused sauces, dubbed Mav Sauce, in 2018. At first, she developed cannabis pesto, ketchup, mustard, maple syrup, honey, and BBQ sauces, and her rise in popularity on social media prompted her to expand her sauce lineup to include new flavors including jerk BBQ sauce, Memphis sweet BBQ sauce, vegan chipotle aioli, organic maple syrup and honey, balsamic vinaigrette, sriracha ketchup, and sweet chili sauce. Her infused sauces became so popular that she wrote a cookbook incorporating them, released in May 2023. Sauced Up! 420 Recipes Featuring Mav Sauce includes 14 recipes that offer creative ways to use her various Mav Sauces, such as adding her infused Memphis sweet BBQ sauce to smoked BBQ jackfruit enchiladas or using infused pesto in a Caprese stuffed mushrooms recipe. Maverick later developed dietary-friendly infused sweets called Mav Snacks after her savory successes. These include a variety of options from rice cereal-based treats to cookies, brownies, gummies, and more that are gluten-free, soy-free, and some of which are also vegan. According to Maverick, her fruit juice gummies are some of her bestsellers. “Certain gummies may have two flavors; some of them have three,” Maverick says. “So it may be pineapple, watermelon, and strawberry or something like that, you know, so people love them for that, and they’re very good.” Her vegan strawberry lemonade cookies, including a lemon-flavored cookie with strawberry jam in the center and a drizzle of strawberry lemonade icing, are also a bestseller and one of her favorites. Not only are Maverick’s sauces and snacks packed with flavor, but she also maintains high standards when using quality ingredients. “The thing about Mav Sauce and Mav Snacks is that they’re exclusively gluten-free, soy-free, and non-GMO. I don’t use crappy ingredients. I use mostly organic ingredients: organic butter, organic this and that, as much as I can. All my herbs are all organic because I feel like cannabis is supposed to be something used to help you feel better,” Maverick says. “But if you’re smoking trash, it’s not going to help you. If you’re ingesting stuff that is trash, it’s just gonna get you high; it’s not going to be helpful. You know? So it’s really important that the ingredients are quality for me, and when I put out a quality product, people can actually benefit from it versus like most companies, especially these edible brands, are probably in it just because it’s profitable.” Many of Maverick’s long-standing customers are medical patients suffering from a variety of conditions, such as endometriosis, cancer, and Parkinson’s disease. She recounts heartwarming messages that she has received from fans explaining how Mav Sauce and Mav Snacks have helped them manage their symptoms and improved their quality of life. “I’m just glad that I’m able to help people, you know, through their stuff,” Maverick says. “And that’s really like, for me, the best part of what I do. I really, really love helping people and getting that feedback that what I’m creating, it’s not just gonna get someone high, it’s changing people’s lives.” Maverick moved to Georgia toward the end of 2023, citing being “over L.A.,” but the decision to swap the West Coast for the east won’t hinder her plans for growth. A new chapter is beginning, and Chef Maverick is cooking up even more ambitious plans for the near future. By Chef Maverick Servings: 4 Prep time: 20 mins Cooking time: 25 mins THC mg/serving: 12.5 mg Ingredients 1 lb jumbo shrimp 1 cup shredded coconut 1 cup breadcrumbs ½ cup gluten-free flour (I use Bob’s Red Mill 1-to-1 Baking Flour) 6 tbsp vegan eggs (I use JUST Egg) 1 ½ tsp sea salt ¾ tsp black pepper ½ tsp garlic powder ½ tsp onion powder ¼ tsp ground ginger ¼ cup Mav Sauce Sweet Chili Sauce Oil (for frying) Sriracha (for garnish) Cooking Instructions Notes: Tablespoon of Mav Sauce Sweet Chili Sauce = 6.25 mg THC or CBD. Suggested serving per person = 2 tablespoons. To make a non-infused version of this, simply swap out my Mav Sauce Sweet Chili Sauce for any store-bought sweet chili sauce you desire. To make a vegan version, simply substitute vegan konjac shrimp instead of real shrimp. Excerpted from Chef Maverick’s cookbook Sauced Up! 420 Recipes Featuring Mav Sauce. This article was originally published in the April 2024 issue of High Times Magazine.

https://hightimes.com/

Weed Made Me Less Angry. Now It Sometimes Makes Me Mad.

The battle for self-improvement is ever-present and ongoing. While we’d love to remain on a constant upward trajectory, the reality is that internal and external factors regularly loom in the shadows, often serving as roadblocks and setbacks to our personal development.  Growing up, anger was a frequent passenger in my life’s journey. A regular overwhelming fixture from my teens to mid-20s, frustrations often boiled into anger and unpleasantness. It was a period of my life that I’m now embarrassed by, particularly my pathetic ability to devolve into a whiny loudmouth far too fast and often. Today, at 37, I’m mostly calm, though some may say otherwise.  Weed helped play a significant role in changing my perception and approach towards life over the years. Combined with other mental health measures, I’m happy to report that I’ve been largely content for much of the last decade. That said, recent developments in this industry have challenged my mental homeostasis and my upward trajectory at times.   I developed a short fuse early on, starting around my pre-teens as a schlubby fly on the wall. My anger was a simmering stew during my earlier years, starting as a pre-teen. My feelings were a grief gazpacho created by a recipe likely known to many readers. It combines family with your own flawed life decisions. Toss in a dash of factors outside your control, and boom, you’ve got the recipe for a damn fine anger soup.  From about 12 to 20-something, I developed a track record of being irritable, difficult at times. I was pretty damn annoying. I stewed on slights and regularly strived to defy previous bullies, bosses, and others. By college, I was an often pissy, angry little thing who took far too much influence from the “I’mma let you finish” Kanye West era. I loved to rant and vent, all while being a stone-cold, largely uneducated dipshit.   By my mid-20s, I was an asshole more often than not, ready to bite back or even bite first if I sensed bad times on the horizon. I must confess, I was proud of this back in the day. I thought I had toughened up and protected myself from perceived dangers. For more than a few years, being an asshole was my natural default. Defensive stances, often supported by anger, kept me safe and protected. But over time, I realized that I didn’t like who I was or where I was going. A quarter of my life in the books, I needed peace for myself and the people around me. I had smoked pot since I was 18, but I never saw it as anything more than recreational. That changed when I needed to recalibrate my thinking.  Around 26, I found myself in an embarrassing state of affairs. I was reeling after an embarrassingly short stint living in LA a year or so prior. Since then, two relationships had gone to crap, leaving me broke, lonely, and wondering what would become of my life. I was upset about work, life and losing badly in FIFA ‘13. Around 2013, I started exploring how I can better myself. Along the way, I realized how extensively weed helped me think introspectively, examining the pros, cons, and everything in between. I credit this to a roommate who always had a quarter pound of weed and was down to share. You’re a good dude, Mike. I owe you tons.  Unfortunately, due to a lack of medical insurance, it took me another year before I finally started going to talk therapy. In the intermediate, weed and the occasional psychedelic helped create a largely positive effect.  By 27, I was more than ready for change. I had gone to a therapist during the summer of my first year in college. I learned quite a lot in just a few weeks. This time, I knew I would be going much longer. Talking helped—almost as much as listening. However, it took me about a year to start listening. That only came about after my therapist told me I don’t shut up and often cut people off. He told me I was tactless, which sounded tactless in itself. But maybe that’s what was needed to stick in my mind.  Two or three years into biweekly talk therapy, my general doctor recommended a nonaddictive pill for when I felt anxiety attacks coming on. I had previously thought those feelings of chest tightness were minor heart attacks brought on by overeating buffalo chicken and ice cream. I guess I was happy to learn I was more prone to controllable mental breakdowns rather than early on-stage heart problems.  At peak usage, I’d take about 10 or less pills every month. I stopped taking them in 2021 or 2022, I forget. Unlike pills, I never stopped using weed and shrooms. I don’t plan on changing that, either. While anti-anxiety meds did keep me in check, plant-based substances have always helped me open my mind to new ideas, perspectives, emotions, and better ways of living. I hope it stays that way. I’d love to say I’m cured. I’d love to say that anger is in the rearview and now I live life positively all the time. But that would be a lie.  Truth is that I often struggle with feeling angry, uneasy, upset, whatever you want to call it. I probably will my whole life. As much as I’d love them not to, things get under my skin, whether I like it or not.  Every day is an ongoing test to keep my feelings in check. After years of hard work, most days go by with anger barely present. I have clarity, breathing techniques and a cute dog to keep me grounded. This ongoing fluid management is part of my mental health regimen. Much like my cardio and strength training, there are days I do well and others I come up short. I’m trying to do my best, and on most occasions, I think I hit that mark. While I type that last paragraph with sincerity, I am fully aware that there are friends, colleagues, strangers, and the occasional client that may call bullshit. You know what? They may be right. And if it’s any solace to them, I very likely replay our interactions occasionally, just so I can scrutinize my actions.  I don’t like being angry, but I don’t mind getting there when I need to be. In life and work, it has helped in moments. If an older man calls a bunch of teens on the subway the C-word, then I might yell at him and make sure he stays off the train. If a client refuses to pay for services rendered, I might stand up, flexing my legal rights when needed. If a shithole news outlet steals my work, I may blast them online, even if it leads to them responding with a cheeky parody of me that’s very likely to give the publisher their first erection in years.   But, I do often wonder if I made the right decision.  I must admit that being in the weed scene sometimes pulls me down.  I appreciate this job and the life it’s created for me. But I miss getting high, having fun, and not having to deal with industry grandstanding, or even worse, uneducated people thinking they understand the nuances, when in reality, they’re often the most misinformed person in the room.  For a plant associated with euphoria, there’s plenty in pot to make a person mad. Often, the source of anger isn’t in regards to righteous causes such as the freedom of drug war victims or fair and affordable access to cannabis through means like home cultivation.  The source of the frustration is typically detrimental people and actions. The vast majority of the movement is well-intentioned and good. However, examples of the opposite run long and deep, creating a troubling sliver that may include:  But let’s also point the finger at ourselves on occasion. There’s a lot to be disheartened about when it comes to weed consumers.  People flock to boof almost as much as they do clickbait-y, rage-bait content. And look, that’s life. People love looking at accidents, commenting on hot button posts, and smoking sus weed sprayed with terps so that the plant tastes like cotton candy. In short, people are attracted to stupid shit more often than not.  We’re not stopping these habits. But, as a media professional, all I ask is that the “readers” first step off their soapbox before banging on about how they want to see positive content.  Let’s be real: Traffic data shows that most people don’t read positive stories, no matter what they say. I’ve tried getting positive pitches approved by various outlets. Sadly, the traffic numbers often don’t warrant the commissioning, and that sucks.  But let’s be honest. Most people don’t read at all, especially long op-eds like this.  Okay, don’t read. Be dumb. That’s your choice. But all too often, these same cabezas full of caca who don’t educate themselves want their opinion to matter on the same level as someone who’s informed on this matter.  I know I’m an old man yelling at clouds here, but for the love of God, read before commenting. Otherwise, you’ll risk throwing your neck out during all that digital self-fellation. But hey, at least this is a worldwide problem and not just a weed thing, right?  Anger is like cayenne pepper. A sprinkling gives you the kick needed to make something right. Too much, and you’re potentially in for an uncomfortable experience.  Managing your temper requires various approaches depending on your unique circumstances and needs. I believe that pot has played a crucial role in helping me see through nearly three decades of mental fog and stormy seas of strife to get me where I am today. Through prolonged talk therapy and weed, plus a sprinkling of psychedelics and anti-anxiety meds, I’ve been able to get my anger mainly under control.  While I hope the day does come eventually, I doubt I’ll ever be anger-free. So, I’ll just keep pushing the rock up the hill, hopefully finding ways not to slide back as far as I have in the past. And after all, isn’t that all we can ask of ourselves? If we can’t change society or the industry, at least we can try to become the best version of ourselves, right? 

https://hightimes.com/

Louisiana Legislative Committee Unanimously Passes Adult-Use Cannabis Framework Bill

The Louisiana House Health and Welfare Committee recently passed House Bill 707 in a unanimous vote to propose a regulatory framework for the state’s cannabis legalization. The measure, which prefiled in March, doesn’t directly legalize adult-use cannabis but it does start the process of building a foundation for reform. The goal, according to Rep. Edmond Jordan who introduced the bill, is to attempt to get HB-707 passed in the legislature in 2024, followed by introducing two other bills in 2025 which would address adult-use possession and cannabis taxes. Toward the end of a meeting on April 24, Jordan spoke about HB-707 to the House Health and Welfare Committee. “This is a very simple bill,” said Jordan. “What it does…it is for the adult use of cannabis. It sets up the retail side with dispensaries and how we would do that.” The bill would allow adults over 21 to purchase one ounce of cannabis every day, and would also allow residents to pay $75 per year to obtain a permit to grow up to six plants at home (with a maximum of 12 plants). Jordan projected that if adult-use cannabis sales were legal, it could potentially provide more than $1 billion in tax revenue over the next 10 years, which includes an estimated $100 million annually going into the state general fund. Marijuana Policy Project southeast legislative manager, Kevin Caldwell, was also present to discuss the prospect of adult-use cannabis in Louisiana. According to a report created by Vicente law firm’s economic forecaster model created for Louisiana, there are currently 430,000 adult-use cannabis consumers in the state, and by 2033 the industry could be valued at $900 million. “The total regulated market between 2024-2033 would be $5.8 billion,” Caldwell stated, adding that the report believes Louisiana adult-use cannabis could be put in place by 2027, and between 2027-2023, the industry could be valued at $1.17 billion. This was based on Rep. Barbara Freiberg’s adult-use tax bill which was introduced in 2023, and included a proposal of current local and state taxes, with the addition of a 15% excise tax. The adult-use cannabis industry fiscal impact, according to the report, would also generate $13.4 billion between 2027-2033. The report utilized data from all 24 states with legalized adult-use cannabis. Caldwell answered numerous questions from Rep. Rhonda Butler about how the report developed the projected numbers, and the effects of crime increasing in legal states (research shows that it hasn’t led to an increase in crime), and the regulation of potency. A total of 17 amendments for HB-707 were also adopted during the meeting, including transferring management of a cannabis program from the Louisiana Department of Agriculture and Fisheries to the Louisiana Department of Health (LDH), the removal of a cap on licenses that the LDF can issue to cultivators, processors, and manufacturers, changes a license requirement regarding stakeholder disqualification if they were guilty of or plead guilty to a cannabis-related conviction, and removing a penalty for civil violations. One individual spoke in opposition about the bill in regard to claims about the impact of cannabis use among youth. “We don’t need to bring this scourge into our state. We just don’t,” they said. Jordan returned to the podium to speak about the reality of cannabis in Louisiana. “Look, we’re not bringing this into the state, it’s already here. So let’s not ignore what we already have here,” Jordan explained. “The real issue is: do we want to regulate it, do we want to make it safer for our kids, do we want to make sure that we don’t have this laced with fentanyl in some grey or illegal market. I think if we bring it above ground, we regulate it, we’re able to test it, we’re able to do all these other things to make sure that it’s safe, it’s gonna make it better for our kids.” Jordan asked that the bill be sent to the floor for further discussion, where he can present evidence that contradicts what the opposition discussed. Ultimately the committee voted 10-0 to approve HB-707. Successful cannabis legislation has been hit or miss over the past few years in Louisiana. In April 2023, a bill to decriminalize cannabis was killed in committee before it was able to reach the House floor. In June 2023, House Bill 286 was signed by Gov. Jeff Landry, which implemented expungements for those who have previously been convicted of cannabis possession. In March 2024, the state’s 10th medical cannabis dispensary opened. Also recently in March 2024, Louisiana police reported that rats had infiltrated confiscated cannabis and were eating all of the flower. AP News spoke with a police superintendent who said that the “uncleanliness is off the charts,” at that particular building, and it’s not the janitorial staff’s fault.

https://hightimes.com/

Vegans Rejoice as Farmers Switch from Chickens to Hemp

Poultry farmers who raise chickens for slaughter are switching to industrial hemp farming, a trend that has taken place over the past few years. The reason? Hemp is among the crops that requires some of the fewest resources. It’s a hardy and easily renewable crop, and its active compounds like CBD make it more valuable than other industrial crops.  Vegan advocates have been after chicken farmers for some time now. Totally Vegan Buzz profiled a handful of farmers from multiple states on April 24 who are switching from poultry farming to hemp farming. Some of the farmers they talked to previously raised poultry for Pilgrim’s Pride Corp., an American, multinational food company—one of the largest chicken producers in the United States, and a frequent target of vegan organizations.  Pilgrim’s Pride received numerous criticisms in the past for multiple reasons including both the treatment of animals and of employees. Beyond the benefits of hemp, however, vegan advocates are primarily concerned about the treatment of chickens and other animals. Chicken nuggets? Ironically, vegan veggie nuggets that mimic the taste of chicken nuggets often contain hemp hearts or other hemp ingredients. But most hemp farmers that are making the switch are growing hemp for industrial purposes. The New York Times reported in 2016 that West Virginia farmer Mike Weaver, previously raised chickens under contract for Pilgrim’s Pride but switched to crops including hemp. One advocacy group calls the switch “Transfarmation.” There are multiple financial perks of growing hemp, and the industry continues it steady pace of growth. The global hemp derivative market is predicted to reach an estimated $15.2 billion by 2030 with a CAGR of 15.3% from 2024 to 2030. The major drivers for this market are expanding scope of industrial hemp cultivation and growing demand. The “Hemp Derivative Market Report: Trends, Forecast and Competitive Analysis to 2030” report by ResearchAndMarkets.com provides more details. Tom Lim, a Cambodian transplant who raised over half a million chickens each year for Pilgrim’s Pride. He explained one of the reasons why poultry farmers are switching to crops like hemp and vegetables, including the setbacks of raising chickens. “Many poultry farmers get sick due to breathing inside the [chicken] house”, he said. Lim and his wife Sokchea transitioned from running a poultry farm to produce.  “Growing vegetables on my land has always been my dream,” he said. “It’s the healthy way to make food. In the chicken house, you contend with ammonia, odors, and insects. But entering a greenhouse—it feels fresh and healthy.” Vegan morals have woven their way into the story, and the topic permeates into popular media. The Guardian reported last December that the popular stop-motion animated film Chicken Run and its sequels can be interpreted as “a vegan morality tale.” It’s vegan-coded, many people have speculated. In 2021, a farmer started an initiative to help chicken farms convert to crops like hemp. The Transfarmation Project is an initiative from the advocacy group Mercy For Animals, and they help businesses convert their businesses from raising chickens for slaughter to growing crops like industrial hemp. “Our Transfarmation team provides resources and support to industrial animal farmers interested in transitioning their farms to plant-focused operations, the organization states. “The resources we create and data we collect are accessible to other farmers and organizations to facilitate widespread farm transitions, thereby contributing to societal good.” The Transfarmation Project highlights many farms that have converted to hemp as well as other crops, such as mushrooms or produce. Mercy For Animals highlighted a family farm run by the Halley family in Cookeville, Texas. For 30 years, the farm “raised six flocks of chickens a year—192,000 birds per batch,” they said. But the family-run farm converted to hemp. You can watch a video clip of the transformation on YouTube. “This is the very first successful transfarmation,” said Mercy For Animals president Leah Garcés. “There are 12 chicken houses, and they used to house tens of thousands of suffering animals, and now they are going to dry hemp. That is just so beautiful, to see the transformation, the possibilities that can come when people come together and try to find solutions. … I am going to work hard to make the chicken houses turn into something that [farmers] can make money off of, that can sustain the land and their families.  It is such a moment of creation and growth rather than destruction and death. And I just want to be a part of that.” More farmers are considering the viability of growing hemp instead of raising poultry and other farm animals.

https://hightimes.com/

DEA Challenges Bid To Use Psilocybin Under ‘Right To Try’ Legislation

The U.S. Drug Enforcement Administration has urged a federal appeals court to deny a doctor’s attempt to administer psilocybin to dying patients under so-called Right to Try legislation, arguing that such laws do not provide for exemptions to the federal Controlled Substances Act (CSA).  Dr. Sunil Aggarwal, co-founder of the Advanced Integrative Medical Science Institute, a psychedelics research and treatment clinic based in Seattle, has sued the DEA several times for authorization to use psilocybin as a treatment for depression and anxiety by terminally ill patients. Aggarwal’s legal actions are based on federal and state Right to Try laws, which permit patients with terminal illnesses to use investigational drugs for therapeutic purposes before they are approved for general use by the Food and Drug Administration (FDA).  Psilocybin, the compound primarily responsible for the psychedelic effects of magic mushrooms, has been shown through clinical research to have great potential as a treatment for serious mental health conditions including depression, anxiety, post-traumatic stress disorder and substance misuse disorders. The compound has been designated as a “breakthrough therapy” by the FDA but remains a Schedule I drug under the CSA, a classification reserved for drugs with no medical value. The state of Washington approved a Right to Try bill in 2017, the same year former President Donald Trump signed the federal Right to Try Act into law. Aggarwal argues in his legal action that the legislation gives him the right to administer psilocybin to his patients with terminal illnesses. The DEA, however, has rejected Aggarwal’s attempts to gain the authority to administer psilocybin to his patients. In its rationale for rejecting a 2022 petition seeking such authority, the DEA argued that treating terminally ill patients with psychedelics would be inconsistent with maintaining public health and safety. Aggarwal also claims the DEA wants him to register as a researcher to administer psilocybin, which is not a requirement of the federal Right to Try Act. Aggarwal appealed the DEA decision to the U.S. Ninth Circuit Court of Appeal, arguing that it was arbitrary and inconsistent with public health interests and established legal precedent. In February, he argued that the DEA must explain how its decision is consistent with the CSA and its own policies, noting that the agency has issued waivers for the therapeutic use of other Schedule I drugs, including the use of medical cannabis by children. In a filing to the court last week, the DEA said that the Right to Try Act amends the Federal Food, Drug, and Cosmetic Act but does not affect the CSA. The agency also said doctors who wish to administer controlled substances must abide by both statutes. “The CSA and the FDCA (which the Right to Try Act amends) are separate regulatory schemes with separate requirements and restrictions,” the DEA wrote, as quoted by Green Market Report. “Nothing in the Right to Try Act changes that.” The DEA also argued that the court should reject Aggarwal’s claims because he has not provided sufficient evidence to support them. The law enforcement agency also said it could not adequately evaluate his plan to administer psilocybin because he did not give enough information to justify the waiver he was requesting. Shawn Hauser, a partner at the cannabis and psychedelics law firm Vicente LLP, slammed the DEA’s position, saying the agency “continues to overtly misinterpret the law using unlawful delay tactics to deny terminally ill patients access to life-saving medicines that federal law affords them access to.” “Federal Right to Try laws were designed to allow eligible, terminally ill patients who qualify to use investigational new drugs that have undergone clinical trials (such as psilocybin), even if they are Schedule I substances,” Hauser wrote in an email to High Times.  “The law includes a clear exception to the FDCA’s safety/efficacy requirements that allow the use of unapproved, investigational drugs, such as psilocybin, that have completed successful FDA trials, by terminally ill patients,” she added. “This seems to be another excuse and obstruction by the DEA to deny patients access to a life-saving treatment that studies clearly demonstrate can be used safely as medicine.”

https://hightimes.com/

Study Reveals State Cannabis Legalization Lowers Immigrant Deportation

There’s yet another compelling reason to legalize weed. According to new research, states that have legalized cannabis also experience a “moderate relative decrease” in immigrant deportation rates compared to states where the drug is still illicit. As a study featured in the American Journal of Community Psychology details, immigration raids and deportations create widespread fear and mistrust, which have cascading effects throughout entire communities. As the fear of being targeted grows, people are less likely to engage with local institutions such as churches, schools, health clinics, cultural events, and social services.  And it also finds that kids who experience the sudden, forced deportation of a parent often suffer from a range of psychological issues including anxiety, anger, aggression, and withdrawal. They may also exhibit a heightened sense of fear, trouble eating and sleeping, PTSD, and depression. While these conditions can be treated with cannabis and therapy, the research on legalizing cannabis and deportation indicates that we could get in front of such troubles if we just legalize it, to begin with.  Of course, it’s not just immigrants, although better immigration policy benefits everyone. The study, conducted by researchers from Columbia University, also notes a slight reduction in overall cannabis-related arrests. The authors of the study stated that recreational cannabis laws (RCLs) could “help to mitigate some of the unintended immigration-related consequences of cannabis prohibition.” They observed that “Arrest trends in both legalization and non-legalization states were relatively similar and generally stable over the period.” They also found that the trends suggested that the overall prevalence of deportations went down between 2009 and 2020. Here’s a bit more of what they had to say: “Our results suggest that the RCLs were associated with a moderate relative decrease in deportation levels that was observed relatively consistently across multiple model specifications. Findings also suggested potential relative decreases in immigration arrest levels; however for almost all specifications, associated confidence intervals were wide and included the null. Together these findings support the overall possibility that RCLs may help to mitigate some of the unintended immigration-related consequences of cannabis prohibition.” About ten percent of U.S. families with children have at least one family member who doesn’t have citizenship, and it’s estimated that nearly six million kids have at least one caregiver without authorization to live in the country, putting them at risk for the aforementioned trauma and related mental health conditions.  The authors of the study didn’t draw definitive conclusions about the apparent link between state-level cannabis legalization and reduced deportations. However, it is noteworthy that all 11 sanctuary states for immigrants (California, Colorado, Connecticut, Illinois, Massachusetts, New Jersey, New York, Oregon, Rhode Island, Vermont, Washington, D.C.), which generally discourage reporting immigrants to federal authorities, have also legalized cannabis for adult use. The research leads to the conclusion that legalization generally results in fewer arrests for cannabis-related offenses, suggesting that fewer immigrants are likely to be implicated in marijuana criminalization from the get-go. The researchers identified two “countervailing pathways” that they described as “relevant to anticipating the potential immigration implications of RCL adoption,” which are as follows:  “First, RCLs could lead to potential decreases in the overall number of cannabis-related arrests or convictions, and therefore cannabis-related immigration enforcement. A second possibility, however, is that state adoption of RCLs might lead more people who are non-citizens to reasonably but falsely assume that federal immigration status is unaffected by cannabis use permissible under state law—potentially leading to increases in immigration enforcement.” So basically, simply legalizing marijuana for everyone will naturally lower the number of people who are deported for daring to enjoy weed. However, there is also a chance that if recreational cannabis laws are passed, people who aren’t legal citizens might feel an unfortunately safe, false sense of security.  The study explains that even though some states have legalized cannabis, don’t forget that it’s still illegal under federal law. This means that any cannabis-related offenses, even seemingly minor ones, can have serious repercussions for non-U.S. citizens such as permanent residents, DACA recipients, and those granted asylum. According to federal policy, simply being charged with or admitting to possessing a small amount of cannabis can lead to problems with U.S. Immigration and Customs Enforcement (ICE), including affecting immigration status or even leading to arrest, detention, or deportation. This is also true for those who work in the cannabis industry, further narrowing the scope of available labor to immigrants.  So while yes, legal weed on a state level could lead to people feeling too comfortable and forgetting that there’s still the federal government to fear, overall, recreational laws seem to make life easier for everyone, as this new research into its implication on immigration shows. 

https://hightimes.com/

Arizona Church Reaches Settlement with DEA To Allow Sacramental Use of Ayahuasca

An Arizona church has reached a settlement in a lawsuit against the U.S. Drug Enforcement Administration and other federal agencies that allows the Indigenous religious organization to use the psychedelic brew ayahuasca for sacramental purposes. Under the agreement, the Church of the Eagle and the Condor (CEC) will be permitted to import, prepare and distribute ayahuasca to its members at religious ceremonies. “The Church of the Eagle and the Condor has reached a settlement to secure its religious freedom and the right to use Ayahuasca as its sacrament,” the church wrote in an announcement of the settlement. “This is the first Indigenous-based church to receive recognition and protection.” In 2022, the CEC filed a lawsuit against the U.S. Department of Justice, the Department of Homeland Security (DHS), Customs and Border Protection and the DEA after DHS officials seized shipments of ayahuasca intended for sacramental use by church members. The lawsuit also cited government threats that the church and its members could face prosecution under federal drug charges if they continued to import ayahuasca, which contains the psychedelic drug and Schedule I controlled substance DMT (N, N-Dimethyltryptamine). The settlement allows the CEC and its members to obtain and use ayahuasca in paste or liquid form under an exemption to the Controlled Substances Act. The concentrate will then be diluted with water into a ceremonial tea by church members for religious ceremonial purposes held in Phoenix. The settlement permits the DEA to take samples of imported shipments to confirm they contain ayahuasca and no controlled substances other than DMT.  “This Agreement permits CEC to import, receive, manufacture, distribute, transport, securely store, and dispose of ayahuasca solely for CEC’s religious purposes,” the settlement reads. “CEC may not conduct any of these activities for non-religious purposes, including but not limited to recreational purposes. CEC may not use any DEA registrations subject to this Agreement to import, receive, manufacture, distribute, store, or use any other controlled substance.” Ayahuasca is used in South America by Indigenous cultures and folk healers in spiritual and religious ceremonies. In recent years, the psychoactive brew has gained popularity with American celebrities including Aaron Rodgers, Will Smith, Miley Cyrus and others, who have used ayahuasca to take advantage of its purported mental health benefits. CEC Ayahuasquero (sacramental practitioner) Joseph Tafur, M.D. said in a statement that the ceremonial use of ayahuasca “is an essential sacrament for our church.” “Our ceremony is rooted in the Shipibo Amazonian tradition which has been passed down by countless generations,” he said. “Now, in fulfillment of the ancient Prophecy of the Eagle and the Condor, this tradition has come to North America.”  “I am honored to be an Ayahuasquero with the CEC, and bring to our ceremony the care, respect, and reverence that it deserves,” Tafur continued, adding, “Our ancestral practice will continue to support the community and nourish our holistic well-being.”  Belinda P. Eriacho, a CEC board member of Diné and A:shwii lineages, said that the settlement with the DEA “reaffirms our right to practice our spirituality as we have always known. It is a recognition by the U.S. government and an important milestone in honoring and validating indigenous belief systems. Prior to contact, indigenous peoples have used sacred plant medicines for healing and ceremony since time immemorial.” “Our relationship with our plant relatives has always been an extension of our worldview. This has been interrupted by the imposition of governmental policies that have suppressed our way of life and demonstrated religious intolerance,” Eriacho continued. “This settlement is a significant step and acknowledgment of our spiritual beliefs as original peoples of the Americas.” 

https://hightimes.com/

Sweden Authorities Seize 1.4 Tons of Cocaine, ‘One of the Biggest’ Seizures Ever

According to a Swedish customs official, authorities confiscated approximately 1.4 tons of cocaine last week in a port near Stockholm, as reported by Associated Press. While the precise figure is still pending, Swedish customs official Stefan Granath told broadcaster SVT, “If it’s as big as we think, it is one of the biggest seizures ever made.” Authorities discovered the cocaine in a container in the Nynashamn port south of Stockholm on April 18, according to Granath. Six men have also been arrested on suspicion of involvement in the drug’s transport. Granath noted the size of the seizure, saying that only five to 10 years ago it was “very unusual” to seize only 100 kilograms, or 220.5 pounds.  To put it in perspective, 1.4 tons is equivalent to 2,800 pounds. That’s more than the volume of total cocaine seized by Sweden in 2022, and the country’s previous cocaine seizure peak — 822 kilograms or 1,812 pounds. The prior record was set in 2018, with 300 kilograms or 661 pounds of seized cocaine. Granath also added that it’s likely that the cocaine was meant for the European market and that Sweden was only a point of transit. It’s historic for Sweden, but it also acts as one of the more significant drug seizures for Europe as a whole.  Earlier this year, Portuguese authorities discovered 1.3 tons of cocaine within shipments of frozen fish, similarly expected for distribution across Europe and unloaded at the Lisbon port. Authorities noted that the way the drug was hidden made it extremely difficult to detect and that the frozen fish had to be completely destroyed in order to remove the cocaine. In 2023, Netherlands customs agents seized a whopping 17,600 pounds of cocaine hidden inside crates of bananas in what was the largest haul ever collected in Rotterdam’s port, the largest port in Europe that had processed more than 220 million tons through its terminals in the first six months of 2023. According to Swedish radio, the recent figure and seizure is indicative of more efficient search methods and an increase in the flow of drugs as a whole.  Demand for cocaine appears to be growing rapidly across the European Union, with governments blaming the drug trade for increased violent outbreaks in major port cities like Antwerp in Brussels, Rotterdam in the Netherlands and Marseille in France.  On top of some of the other recent busts, Antwerp customs reported that it had seized 116 tons of cocaine in its port throughout 2023, setting a record for the second year in a row according to an Associated Press report. EU member countries stopped a total of 303 tons of cocaine in 2021, the most recent year for which figures are available. AP reports that 75% of that quantity was seized in Belgium, the Netherlands and Spain. Outlets have suggested that the European drug boom is impacting neighboring countries like Sweden. EL PAÍS notes that the Swedish government opted to put the army on the streets last September to combat a wave of murders linked to gang rivalries. Sweden now has the second-highest gun crime death rate in Europe, with poverty and inequality as driving factors as well as arms and drug trafficking. It’s a stark shift over the past several years, as Sweden’s once peaceful image has been drastically altered by an increased onslaught of gang violence. “What started out as gun violence between young gangs looking to defend their territory has turned into a vicious circle of firearms trafficking and gun violence,” said Nils Duquet, a firearms researcher based at Brussels’ Flemish Peace Institute. “Gangs have also matured and are no longer just the street criminals, but are often connected to higher-level criminals as well.”

https://hightimes.com/

Gov. Kathy Hochul Honors New York’s 100th Adult-Use Retail Store Opening

In an announcement last week, Governor Kathy Hochul announced that the state of New York reached a significant milestone: the grand opening of the state’s 100th Conditional Adult-Use Retail Dispensary (CAURD) brick-and-mortar store.  Big Gas is located in the village of New Paltz, located near Poughkeepsie. The Office of Cannabis Management (OCM) and a handful of state leaders joined Big Gas owners, Kareem Haynesworth and Zymia Lewis for the grand opening of the store for public sales. “Big Gas is proud to be the first licensed cannabis dispensary in the City of New Paltz,” Big Gas Owners Zymia Lewis and Kareem Haynsworth said. “We are here with the support of the New York State Cannabis Investment Fund, who led us to this great location. This is beyond our wildest dreams.” “We are pleased to be a host community in NYS’s Conditional Adult Use Retail Dispensary program,” said Village of New Paltz Mayor Tim Roger. “This initiative has allowed the state to 1) invest in a private fund to support individuals impacted by the inequitable enforcement of cannabis law and 2) protect public safety with NYS-sourced, regulated, and tested cannabis.” Hochul applauded this historic milestone for New York’s cannabis industry. “New York State continues to make progress on standing up a safe and legal cannabis industry for business owners, farmers and residents across the state,” Governor Hochul said. “Today marks a historic milestone in establishing a thriving and equitable industry in our state with the 100th brick-and-mortar store opening.” New York officials licensed 110 adult-use cannabis retailers including storefronts and temporary delivery-only (TDO) locations across the state, with more anticipated to open soon. It’s a mix of CAURD licensees with storefronts, CAURD licensees providing delivery services, and adult-use dispensaries co-located with existing medical dispensaries.  New York industry is taking off, reflected by the rapidly growing number of retailers and sales, with total sales exceeding $237 million, $77 million of which was generated in the first two and a half months of 2024. It’s all the signs of a thriving market. The rollout of New York’s cannabis program, however, was hammered by delays caused by lawsuits and the prevalence of illegal cannabis retailers. One such delay was a lawsuit led by Leafly that challenged New York’s ban on third party advertisers for cannabis businesses. New York places emphasis on social equity measures to ensure that the state’s industry includes communities impacted the most by the criminalization of cannabis. Despite setbacks, state leaders have been optimistic. Within its first year of operation, New York achieved and surpassed the Social and Economic Equity (SEE) goal laid out in the adult-use law with 60% of licenses given to social and economic equity applicants. Forty percent of social equity licenses are minority-owned businesses and 40% are women-owned businesses, respectively. The governor’s announcement stated that this also almost doubled the percentage of majority minority-owned cannabis retailers nationwide. As of April 2024, 37% of New York’s adult-use retailers are majority minority-owned as only 19% are majority minority-owned nationwide.  In addition, 11% of New York’s adult-use retailers were majority Black-owned, while nationally, that number is at just 2%. Approximately 50% of New York’s open dispensaries are minority- and/or women-owned businesses. Office of Cannabis Management Executive Director Chris Alexander said, “We are incredibly proud of our licensees across New York State who have worked diligently to cross this threshold. Today’s celebration at Big Gas belongs not only to the team who opened their doors to business to eager customers today, but to every single licensee who is building this market from seed to sale. It echoes our commitment to catalyzing growth, fostering diversity, and championing equity within the cannabis sector. This milestone embodies our tireless endeavors to reshape the industry landscape and underscores our resolve to push the boundaries of progress. Supported by the New York Cannabis Social Equity Investment Fund, we take pride in our progress and pledge to persist in our pursuit of inclusivity and advancement of New York’s Cannabis Market.” “We take great pride in being able to support individuals who have been affected by unjust enforcement of cannabis laws and help them thrive in this emerging industry,” said Social Equity Impact Ventures LLC General Principal of the Fund’s General Partner Lavetta Willis. “Access levels the playing field. We are thrilled for Zymia Lewis and Kareem Haynesworth and wish them great success. We express our heartfelt gratitude to Governor Hochul for leading the way and paving the path to a socially equitable sector that promotes inclusivity and equal opportunities for all.” Hundreds more retail operations dot the state as licensed businesses compete with the black market.

https://hightimes.com/

D.A.R.E. Officer of the Year Discusses Relative Using Medical Cannabis for Cancer

The Drug Abuse Resistance Education, aka D.A.R.E., has been teaching kids about substance abuse since 1983 with a mission of delivering science and evidence-based curricula. Recently, a D.A.R.E. documentary published by Channel 5 with Andrew Callaghan on April 12 spoke with numerous individuals regarding the D.A.R.E. program and discussed the failure of the War on Drugs. Callaghan attended D.A.R.E.’s annual conference, which was held in Las Vegas, Nevada last July. An estimated 500 attendees were present for D.A.R.E. officer training. Part of the conference included presenting awards for 2023 D.A.R.E. Student of the Year and 2023 D.A.R.E. Officer of the Year Mark Gilmore, from Kosciusko, Mississippi. Gilmore commented on his ability as a D.A.R.E. officer to apprehend any students who possess any amount of drugs, which includes even the smallest amount of weed. D.A.R.E.’s 2022 Officer of the Year, Alex Mendoza of the Irvine Police Department spoke with Callaghan about shifting D.A.R.E.’s approach to drug prevention deterring kids from using drugs. “For me, it’s really about educating the youth that are out there,” Mendoza said. “To give them the tools necessary to navigate whatever pain that they’re going through. I think that if you don’t have that self-love for yourself and that resiliency, then you’re gonna go to that external source, whatever that might be.” Callaghan asked, “Do you feel the same way about alcohol?” to which Mendoza replied, “Absolutely. I mean, alcohol is a gateway drug.” Callaghan then asked Mendoza if he drinks alcohol, and Mendoza confirmed that he does so rarely, or “maybe once or twice within a month period of time.” He gave an example, stating that he recently had an alcoholic drink at his daughter’s wedding during a toast. Callaghan addressed this issue in the documentary, citing the validity of calling alcohol a gateway drug. He asked Mendoza if he felt cannabis could be treated in the same way as alcohol. “You know, there’s so many things about marijuana that go far beyond, I guess, really our understanding, right?” said Mendoza. “From a lot of the statistics that are out there, obviously, they say that it can be more dangerous than tobacco products.” However, he did note that there are many instances where cannabis is being used to help patients to deal with the symptoms of their condition. “I think the problem that you run into is that you have the people that truly legitimately have a need and a purpose behind it and will use it to help them navigate their pain,” said Mendoza. “My brother-in-law recently passed away of cancer, and he didn’t want to go with any type of prescription medication. He wanted something natural and he resulted to using THC to deal with his pain. And it helped him. He passed away, but it helped him navigate that, right? And then you have, unfortunately, people that will use that as an excuse to try to use that product for recreational purposes.” D.A.R.E. President and CEO Francisco Pegueros, who formerly worked for the Los Angeles Police department, concluded the conference with a speech. In a one-on-one interview, Callaghan mentioned that people being critical of the War on Drugs, Pegueros said “Well, there was some evidence that certain governmental agencies were involved in a lot of activity that were kind of contrary to the whole concept of the war on drugs,” Pegueros said. Callaghan called the “CIA giving crack to Freeway Ricky Ross,” or how the federal government was supplying Ross with cocaine for illegal sales. “It’s an unfortunate part of our history. But evidently, it’s reality,” Pegueros said. The documentary also interviewed one individual named Hailey, who was the only protester outside of last year’s D.A.R.E. conference last year. “We don’t try to outlaw sex. We don’t try to outlaw driving. We don’t try to outlaw guns,” Hailey stated. “We don’t try to outlaw all these things that come with risk but can be easily have these safety measures put in place, much like we do with pharmaceuticals.” Callaghan briefly spoke with Bill Russel, also known as RETRO BILL, who has spoken to kids across the country for more than 25 years in partnership with D.A.R.E. to warn kids about how drugs, including cannabis, are harmful and dangerous. The documentary stated that the D.A.R.E. program cost American taxpayers up to $750 million per year in the 1990s, up until a 1998 University of Michigan study showed that drug use continued to rise between 1992-1995, despite the nationwide prevalence of D.A.R.E. It also reviewed the rise of the War on Drugs through actions from former presidents Richard Nixon and later, Ronald Reagan. Former President Bill Clinton signed the Violent Crime Control and Law Enforcement Act in 1994, and D.A.R.E. lost its federal funding in 1998.

https://hightimes.com/

Cresco Labs Workers Reportedly De-Unionize

Employees at one of the country’s largest cannabis companies have reportedly fled their union amid a dispute over wages and dues. The outlet MJBizDaily reports that workers at one of Cresco Labs’ cannabis cultivation facilities in Massachusetts “voted to de-unionize earlier this month,” which it said was “believed to be the first instance in the U.S. of a regulated cannabis workplace exiting organized labor.” The move comes after workers at the facility in Fall River, Massachusetts “had joined the United Food and Commercial Workers (UFCW) Local 328 in November 2020,” according to MJBizDaily. “Their first contract was set to expire in June. But rather than negotiate a new deal, the workers elected to ditch the UFCW entirely, Cresco employee Wyatt Brissette told MJBizDaily,” the outlet reported on Tuesday. “Sore points among the formerly unionized workers included scheduled wage increases that didn’t keep up with inflation and ‘arguably worse benefits’ than what nonunion workers received, he said.” “We felt as if (the union) didn’t match what we needed,” Brissette told the outlet. “We were pretty much paying them for nothing.” Another outlet, The Dales Report, reported that the exit from the union was “driven by employee dissatisfaction with union dues.” “The Cresco Labs union situation underscores a significant challenge in unionized sectors, especially in emerging industries like cannabis. Although it is widely believed that unionization protects workers’ rights and ensures fair treatment, the recent events at the company reveal a gap between union efforts and member expectations. This situation sheds light on the complexities of union dynamics in newer, rapidly changing markets,” the outlet said.  “Cresco Labs’ employees’ decision to leave their union is not isolated but reflects broader sentiments about the effectiveness and utility of such organizations in certain sectors. As the company continues to grow, the impact of this union departure could influence union strategies and employee relations in similar companies. The Cresco Labs issue may lead to a reassessment of union strategies across the industry. Unions might need to adapt more flexibly to the unique challenges and expectations of workers in non-traditional fields like cannabis cultivation. For Cresco Labs, this change could also prompt updates in their human resource policies and employee engagement strategies to more directly address worker concerns without employee mediation.” According to the company’s official website, Cresco Labs is “one of the largest publicly traded, vertically integrated, multistate cannabis companies in the U.S.” Its stock was trading at below $2 a share on Wednesday, although it is up more than 46 percent year-to-date. Last year, Cresco Labs called off a planned $2 billion merger with Columbia Care, a deal that would have created the largest cannabis company in the United States. “In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders. We want to express our sincere gratitude to Columbia Care for their valuable collaboration and dedication during this transaction,” Charles Bachtell, CEO and co-founder of Cresco Labs, in a statement at the time. “Moving forward, we remain committed to our Year of the Core strategy, which involves the swift restructuring of low-margin operations, improving competitiveness and driving efficiencies in markets where we maintain leading market share, and scaling operations to prepare for growth catalysts in emerging markets. A strong core will enable us to take advantage of the margin accretive, growth opportunities we foresee within this tough economic time for the cannabis industry. While this is not the outcome we originally hoped for, we are confident Cresco Labs is in a stronger position moving forward.” Nicholas Vita, CEO and co-founder of Columbia Care, said that, “after careful consideration,” his company was “confident in the mutual decision to move forward as separate, standalone companies.”  “This is the best path forward for Columbia Care’s employees, customers, and shareholders. We are thankful for the collaboration and partnership with the Cresco team throughout this extensive process,” said Vita. “Over the last 16 months we have reviewed every aspect of our business, remained decisive and have made substantive changes that significantly improved our operations — positioning us with significant strategic and operational strength at this inflection point in the company’s history. We are looking forward to realizing the benefits of these changes as well as focusing on the opportunities in our outstanding footprint in markets with embedded upside; diversified portfolio of brands; our award-winning national retail brand, The Cannabist; recently implemented operational and organizational efficiencies; proactive balance sheet management activities; and meaningful equity capital markets initiatives that will propel Columbia Care into one of the most profitable and resilient companies in the industry over the next several years.” The companies also used the announcement to provide an “additional update”: “the definitive agreements dated November 4, 2022, to divest certain New York, Illinois and Massachusetts assets of Cresco and Columbia Care to an entity owned and controlled by Sean “Diddy” Combs have also been terminated, effective July 28, 2023.”

https://hightimes.com/

Cannabis Industry Has 440,000 Full-Time Workers

More than 440,000. That is the approximate size of the cannabis industry’s labor force in this country, according to newly published research. The data, compiled by Vangst and Whitney Economics, shows that the United States’ legal marijuana industry added almost 23,000 jobs last year, amounting to a 5.4% year-over-over increase. That brings the total number of full-time workers in the industry to 440,445.  The increase in 2023 may be a “sign that the business climate has begun to stabilize somewhat nationally after the turmoil of the past two years,” the report said. More from the jobs report: “Nationwide, annual cannabis sales increased to $28.8 billion in 2023, a 10.3% rise over 2022’s sales. That figure includes all state-regulated medical and adult-use sales, but does not include hemp-derived products. That’s good news for an industry that has endured strong headwinds. After a rough 2022 that saw a contraction of more than 10,000 jobs, sales and hiring stabilized and began trending slightly upward in the second half of 2023. Not all job markets expanded equally. Below the surface, a complex mix of factors were at play.” But the report also pointed to regional variance in the U.S. weed market. “The national 5.4% growth in jobs wasn’t spread evenly. Now more than ever, America’s cannabis industry is a state by-state, region-by-region job market. Young markets in recently legalized states continue to expand and create employment opportunities, while labor demand in mature markets contracts along with revenue and profit margins,” the report said. The growth of the past year “was driven largely by steep-curve expansion in young Midwestern markets — Michigan, Missouri, and Illinois — and the moderate growth of East Coast markets like New York, New Jersey, and Connecticut,” it said. “Meanwhile, mature markets in the West were hit by price compression, oversupply, and competition from hemp-derived products and unlicensed sales. They saw a decline in annual sales and the loss of thousands of jobs. In years past, the cannabis industry sailed steadily on through rough macroeconomic weather. Indeed, cannabis famously enjoyed a ‘Covid bump’ of expanded sales during a pandemic that battered most other storefront retail operations,” according to the report.  “Not so with today’s challenges. The current era of high interest rates and expensive capital has hit cannabis with full force. Cannabis companies nationwide are delaying expansion due to the high cost of debt. As the Federal Reserve indicates it may start lowering rates in later 2024, it’s tough to justify locking in a loan at today’s high rates when cheaper money may become available a few months down the road. Add to that a cash flow concern percolating in many markets: More and more vendors are delaying invoice payments in order to cover their short-term costs. A recent Whitney Economics survey found that 82% of cannabis companies are struggling with accounts receivable issues. That impacts a business’ ability to pay the industry’s famously onerous local, state, and federal taxes — and dampens a company’s ability to hire more staff.” Vanst and Whitney said that there are “bright spots on the horizon” after a period of “alarming revenue decline” in the industry. Last year’s jobs report from the two firms found a loss of more than 10,500 jobs in America’s cannabis industry, which was a first. “Stretching back to 2014, when the first legal adult-use stores opened in Colorado and Washington, the industry had enjoyed job growth of 15% to 41% year-over-year. For nearly a decade, cannabis was America’s fastest-growing industry,” the report explained. But that changed in 2022, “when a postpandemic sales slump coincided with investment pullback, global inflation, rising interest rates, depressed wholesale prices, and changes in consumer purchasing patterns. But while those problems didn’t vanish in 2023, the industry’s job growth was spurred by “the expansion of new and maturing markets in the Midwest and East Coast.” “After an alarming revenue decline, mature markets like Colorado should find a solid landing point and settle into their natural equilibrium over the next 12 to 24 months. Slow-growing markets like New York will continue to expand, and the newly legal Ohio market should open its first retail stores by the end of the year. Meanwhile, lower interest rates in the second half of 2024 are expected to open up the lending window and provide more cash for thriving companies to expand and add needed staff,” the report said. “And, as always, federal reform looms out there as a medium-term unknown. Few expect a significant reform measure (SAFER banking or — long shot — federal legalization) to win approval in Congress prior to 2025. The Biden Administration’s effort to move cannabis to Schedule III continues to grind away, and predictions vary as to the real effects of rescheduling — everything from the unleashing of a new era of post-280E prosperity to a more muted financial effect accompanied by uncertainty around the FDA’s regulatory role.”

https://hightimes.com/

The Cannabis Market Is Booming in Japan

The nascent cannabis market in Japan has reportedly seen a massive increase in recent years.  That is according to a newly published report by Euromonitor International, which revealed a “staggering growth in Japan’s cannabis market over the past four years.” The market, according to the report, expanded “approximately sixfold from JPY4 billion (USD26.3 million) in 2019 to JPY24 billion (USD173.8 million) in 2023,” a surge that was “attributed to the rising demand for products offering relaxation, sleep improvement, and stress relief.” Euromonitor International, a market research firm based in the United Kingdom, said that initial “investment and entry into the cannabis market by major Japanese companies has not been aggressive due to legal uncertainty until now, along with the negative image surrounding its use.” That changed, the company said, in 2024, when Japan amended its “Cannabis Control Law” for the first time in more than 70 years.  “This amendment is expected to significantly change the potential and accelerate the use of cannabidiol (CBD) in diverse fields, including medicine, health, beauty, beverages and edibles in Japan,” the company explained. “While Euromonitor International estimates that 0.12% of the Japanese population are consumers who use illicit cannabis at least once a year, which shows a low figure compared to Western countries, Japan witnessed a surge in illegal cultivation and smuggling operations, particularly among younger generations. Despite the long-standing legal framework, the domestic illicit cannabis market in 2023 was estimated to be 2.5 times larger than the legal CBD market.” The revision to the country’s cannabis law came in December, when Japan’s House of Councillors moved to essentially end the prohibition on medicine derived from cannabis. The amendment also ushered in new penalties for cannabis use.  The punishment for illicit cannabis is severe, carrying a prison sentence of up to seven years. That didn’t sit well with some Japanese lawmakers. “What previously had no penalties will now be harshly punished, with a maximum of seven years in prison. I opposed the bill because there is a serious problem here,” Rep. Taro Yamamoto said at the time. The change to the country’s cannabis law also allows for the cultivation of hemp, a bid to reduce Japan’s imports of the products. According to Euromonitor International, the “momentum for regulatory change in Japan gained traction due to the relaxation of cannabis regulations in other countries, prompting the Ministry of Health, Labour and Welfare to establish an expert panel to review the Cannabis Control Law in 2021.”  “The amendments are mainly twofold: strengthening regulations, and lifting the ban on the use of cannabis-derived medical products,” the company explained. “First, unlike CBD, which is a legal ingredient that can be imported and sold if it is produced overseas, THC, one of the main components of cannabis, will continue to be regulated as a narcotic. In addition to authorised cultivation, the sale and possession of cannabis, which have been punishable up until now, will incur stiffer penalties. Conversely, the government’s decision to permit the practical use of Epidiolex, a CBD-based antiepileptic medication, signals a significant shift in policy. Additionally, hemp cultivation, previously restricted to fiber and seed collection or specific purposes, is now authorized for medical use.” Euromonitor International said that Japan’s “CBD market has been growing rapidly recently, but is still in its early stages.” “CBD products remain relatively unknown to most consumers, with limited understanding and adoption,” the report said. “Concerns over product safety and regulatory compliance persist, highlighted by incidents such as illnesses linked to CBD-infused gummies containing HHCH which are reported widely in the nation in 2023, prompting tighter regulations. The revision of the Cannabis Control Law is expected to usher in clearer guidelines for CBD product sales and distribution, attracting major companies from various sectors to enter the market by 2024. Despite challenges in ensuring quality, complying with regulations, and educating consumers, CBD sales are projected to outpace the illicit cannabis market by 2026, driven by increasing health and wellness awareness among consumers seeking alternatives to traditional products like cigarettes and alcohol.” The company said that it is a crucial time for Japan’s burgeoning cannabis market. “The year 2023 marked a pivotal moment for cannabis in Japan, signaling a potential turning point for the country’s CBD market. Recent legal reforms have opened doors for further CBD establishment and development, with the sector gaining attention as a high-growth industry. The increasing utilization of CBD across various sectors, including health, beauty, beverages, and edibles, is expected to reshape societal perceptions of CBD and cannabis. Nonetheless, lingering concerns persist among Japanese consumers, fueled by reports of health issues linked to CBD products. Key to the market’s success will be companies’ ability to educate consumers about the benefits of CBD products, emphasizing compliance, quality control, and scientific evidence,” the report said.

https://hightimes.com/

Federal Register Proposes Adding Fentanyl, Removing MDMA From Drug Testing Panels

A new article published in the Federal Register in February, which prefaced a digital Drug Testing Advisory Board (DTAB) meeting that was held on March 5. The topic of the article and the meeting covered the Department of Health & Human Services (HHS) drug testing panels and considered adding fentanyl, while also removing MDMA. Section 8105 from the Fighting Opioid Abuse in Transportation Act (which is included in the SUPPORT for Patients and Communities Act) requires the Secretary to justify whether or not to include fentanyl or other Schedule I or II substances in the Mandatory Guidelines for Federal Workplace Drug Testing Programs. The focus on fentanyl is driven by the high number of overdose deaths in the U.S., as well as the fact that fentanyl can be used on its own and not paired with heroin or other substances. “According to the National Forensic Laboratory Information System (NFLIS) 2022 report, fentanyl was the third most frequently identified drug and accounted for 13.81% of all drugs reported by forensic laboratories,” the article stated. According to the proposal, both fentanyl and norfentanyl (a metabolite of fentanyl) would be tested at 1 nanogram per milliliter of blood. The article also mentioned removing MDA and MDMA from the list of drugs tested in the panel “because the number of positive specimens reported by HHS-certified laboratories does not support testing all specimens for MDA and MDMA in Federal workplace drug testing programs.” The National Laboratory Certification Program (NLCP) shows that in 2021-2022, the positive rates of MDMA sat between 0.001%-0.003%, with less than 25% of “positive specimens are likely agency blind samples.” The Substance Abuse and Mental Health Services (SAMHSA), which manages the Center for Substance Abuse Prevention’s (CSAP) DTAB, also considered removing PCP from the drug testing panel. However, decided not to pursue that change. “While PCP has an overall positivity rate nearly as low as MDMA, there are regional differences in positivity, with some areas of the country having much higher rates, so PCP remains a regulated test analyte,” the article stated. During the March 5 digital meeting, SAMHSA led a public presentation covering “Regulatory Program Updates and Mandatory Guidelines.” The goal of the meeting was to discuss a review of the current Federal Drug Testing Program, as well as the state of the Drug-Free Workplace Program. The National Laboratory Certification Program (NLCP) also presented an analysis of the cost and benefits of testing for fentanyl and MDMA. The most prevalent substances tested by the NFLIS in 2022 according to most frequently identified drugs in seized drug exhibits, meth was ranked at number one, followed by cocaine at number two, fentanyl at three, cannabis/THC at four, heroin at five. The ranking substance skip slightly to oxycodone at seven, followed by amphetamine at 13, hydrocodone at 15, and finally MDMA at rank 19. The NLCP also explained that fentanyl testing in urine samples costs $0.23 to $5.00 per specimen for initial testing and $8.00 to $25.00 per specimen for confirmation testing, while oral samples costs $0.80 to $1.00 per specimen for initial testing and $22.00 to $25.00 per specimen for confirmation testing. The total cost estimate to add fentanyl to the drug testing panel could cost anywhere between $ $9,139 to $192,850 per year. However, removing MDMA from the panel would save an estimated $3,800 and $38,000 per year (based on initial testing between $0.10 to $1.00 per specimen, and confirmation testing between $8.00 to $25.00 per specimen). MDMA is ranked as the 19th most frequently identified drug, the NLCP said the cost was negligible. The meeting also invited the public to submit comments regarding the proposed changes, with 115 commenters agreeing with the adding fentanyl to the drug panel and 20 agreed with the addition of norfentanyl. Only 3 disagreed with the addition of fentanyl, citing the expense, the fact that it’s a time consuming process, and also the ongoing truck driver shortages. Many commenters supported removing MDMA and MDA because of the low positivity rate, and how the removal wouldn’t “affect workplace and public safety.” However, many commenters also disagreed with MDMA/MDA removal proposal, claiming that even with a low positivity rate “not testing for it could lead to higher abuse.” SAMHSA provided a graph that showed the drug specimens reported between January 2013-December 2023. During the 10-year period, confirmed tests for 6-acetylmorphine (referred to as 6-am), PCP, and MDMA, all remained low. These potential changes are not yet official, as the DTAB is set to review and publish responses to the public comments. After that, a federal review process will proceed, possibly with revisions, and eventually a formal federal register article will announce the finalization of the changes. Earlier this month, the U.S. Department of Transportation’s Federal Motor Carrier Safety Administration released a report that show year-end data from 2023 regarding the annual decrease of truck drivers. Overall, the number of truck drivers has decreased significantly every year since 2020, with the 2023 number sitting at 858,000. More truck drivers tested positive in drug tests in 2023 than ever before, and a high number of drivers refused to be screened in 2023 as well.

https://hightimes.com/

Feds File Charges Against Maine Weed Grower After Probe Spanning 20 States

A Maine man was arrested and held without bail last week for allegedly operating an unlicensed cannabis operation in a rural area about 60 miles north of Bangor, according to law enforcement officials and court records. Police seized 40 pounds of processed marijuana from a house in Passadumkeag, Maine and arrested Xisen Guo, who is accused of drug trafficking and turning the property into a sophisticated cannabis cultivation operation.  Maine legalized recreational marijuana in 2016 with the passage of a ballot measure that also established a regulated market for adult-use cannabis. The Maine Office of Cannabis Policy said that Guo has not been licensed to cultivate marijuana and was operating the site illegally, court records show. Guo was ordered held without bail on the federal charges on Friday, making him the first person in Maine to face such accusations. Two other individuals who were at the site when it was raided in February were released without charges being filed against them. The grow site was raided after deputies reviewed electricity bills for the property and identified a significant increase in electricity usage. After the rural home was purchased for $125,000 cash, the electricity bill went from about $300 per month to almost $9,000 per month. Investigators said the electricity usage is consistent with the lights, HVAC equipment and other apparatus used in sophisticated cultivation operations. The arrest of the suspect, a naturalized U.S. citizen who was born in China, comes in the midst of a federal investigation spanning several years and 20 states into illegal pot grows being operated by foreign interests. In 2018, police arrested a Seattle woman and seized thousands of weed plants during an investigation of cultivation sites linked to China. In Oklahoma, law enforcement officials determined that groups from Mexico and China started growing pot in the state after medical marijuana was legalized in 2018. Instead of remaining in Oklahoma for use by registered patients, however, the weed was diverted to states where it is still illegal. Last week, U.S. Attorney General Merrick Garland told the Senate Appropriations Committee in response to a question from Republican Senator Susan Collins of Maine that the Drug Enforcement Administration is investigating international criminal groups that are operating illicit cannabis cultivation operations in about 20 states including Maine.  In February, a bipartisan group of 50 lawmakers including Collins wrote a letter to the attorney general asking him to answer questions about reports that China may be connected to illegal marijuana cultivation operations in the United States. “We are deeply concerned with reports from across the country regarding Chinese nationals and organized crime cultivating marijuana on United States farmland,” the lawmakers wrote in the letter, CBS News reported over the weekend. In Maine, the Internal Revenue Service, the Department of Homeland Security, the FBI, DEA and local law enforcement are working together to investigate unlicensed cannabis cultivation operations, Garland told lawmakers. Federal officials say that there are currently about 100 illicit pot grow sites in Maine similar to the one in Passadumkeag. Since June, approximately 40 search warrants have been issued for unlicensed cultivation operations in the state. U.S. Attorney for the District of Maine Darcie McElwee said that dismantling unlicensed cannabis operations with connections to international crime groups is a priority for law enforcement “and we will continue to marshal every tool at our disposal in this effort as appropriate.” So far, state and local police and federal law enforcement agencies including the DEA and FBI are beginning to see success at dismantling illicit cultivation sites, she said, with “dozens of operations” shut down over recent months. “The possible involvement of foreign nationals using Maine properties to profit from unlicensed marijuana operations and interstate distributions makes it clear that there is a need for a strong and sustained federal, state and local effort to shut down these operations,” McElwee said, according to a report from the Portland Press Herald. Raymond Donovan, the former chief of operations for the DEA, told CBS News earlier this month that unusually high electricity bills are one of the easiest ways to identify an illegal cannabis cultivation operation. “These locations consume huge amounts of electricity,” he said. “In order to accommodate that amount of energy, you need to upgrade your electrical infrastructure — and significantly. We’re getting into specialty electrical equipment that is very scarce and hard to come by, especially in the state of Maine.”  Another illicit grow site in Machias, Maine was raided in December after police noticed unusual electricity usage. After the raid, which yielded 2,600 plants and about 100 pounds of processed and packaged cannabis, Machias Police Chief Keith Mercier said that the cultivation site was using about four or five times as much electricity as a typical residence would. “Once we subpoenaed the power records from the power company, [it] was pretty hard to explain why somebody anywhere would be using that amount of power,” he told CBS News.

https://hightimes.com/

Congressional Progressive Caucus Says Dems Can Legalize MJ By Winning House, Senate Majorities This November

It’s a given that Election Season comes with a slew of messages from all sides, and the Congressional Progressive Caucus (CPC) is throwing its hat in the ring with a new legislative agenda, “a vision for Congress to meet everyday Americans’ urgent needs and rebuild the American dream for the poor, working, and middle class,” according to a recent news release from the group. Specifically, the agenda includes a number of priorities like cannabis legalization and expungements that the caucus argues Democrats “can pass with congressional majorities” should they keep the Senate and take control of the House this November, as first reported by Marijuana Moment. The agenda comes as progressive voters have increasingly expressed doubt in the two-party system ahead of the November elections, specifically the ability for the Democratic Party to align with and enact certain aims of progressive voters. Rep. Pramila Jayapal, chair of the CPC, assured progressives that they have been part of the “most significant Democratic legislative accomplishments in the country” while recognizing that there is still ample work to be done. “That’s why the Progressive Caucus has identified these popular, populist, and possible solutions,” Jayapal said. “With the Progressive Proposition Agenda, Democrats in Congress can meet the urgent needs people are facing, rewrite the rules to ensure majorities of this country are no longer barred from the American promise of equality, justice, and economic opportunity, and motivate people with a vision of progressive governance under Democratic majorities in the House and Senate and a Democratic White House.” The document presents a comprehensive legislative agenda surrounding policies meant to uplift poor and working class people. In addition to cannabis-related issues, the agenda looks at raising wages and lowering costs; correcting inequality in the economic, educational and political systems; continuing to push for progressive climate crisis policy and protecting and expanding the rights and freedoms of Americans. The document breaks down policies into a number of focus areas, including legislative policy proposals that Democrats could pass with congressional majorities that the CPC says “will deliver immediate, tangible results for everyday Americans as well as rebuild systems that have held communities back for too long.” Under the “Advance Justice” section, the CPC lists a number of focus areas such as strengthening reproductive rights and LGBTQI equality, comprehensive policing reform, obtaining citizenship and fair systems for immigrants, ensuring respect for tribal obligations, abolishing the death penalty and addressing the legacy of slavery. It also lists marijuana legalization, with the aim, “Legalize cannabis, expunge records, and provide restorative justice for people with marijuana-related convictions.” Specifically, the CPC cites reducing criminalization and incarcerations “through sentencing reform, legalizing cannabis, expunging records, providing restorative justice, and an accelerated and reformed clemency process for people with marijuana-related convictions.” A separate Executive Action Agenda from the CPC last year urged the Department of Health and Human Services (HHS) and the Department of Justice (DOJ) to expedite the review of cannabis as a Schedule I controlled substance, publicly document the progress and timeline for rescheduling/de-scheduling and expedite DOJ guidance to reinstate protection against federal prosecution and interference among state- and tribal-legal cannabis programs. In contrast, the Republican Policy Committee recently shared its agenda in a memo claiming an anti-cannabis reform position, calling cannabis a “gateway drug” causing “violence, depression and suicide.” “Marijuana is a dangerous, addictive drug with no mechanism to control rouge producers from increasing potency and causing more harm,” the new GOP policy guide reads. “Rather than labeling marijuana as a recreational drug, it should be labeled for what it is—a gateway drug that increases schizophrenia and impairs cognitive ability.” It also included two policy recommendations urging members to oppose the Secure and Fair Enforcement (SAFE) Banking and the Cannabis Users’ Restoration of Eligibility (CURE) Act, despite both measures boasting bipartisan support.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.